Interim Phase II results for Nastech's apomorphine

NSTK said that interim analysis of 122 out of 180 men with erectile dysfunction in a Phase II trial of its intranasal apomorphine showed that a 0.5 mg dose taken 15 to 20 minutes before intercourse al...